MedPath

IBSA Institut Biochimique SA

IBSA Institut Biochimique SA logo
🇳🇱Netherlands
Ownership
Private
Established
1945-01-01
Employees
1K
Market Cap
-
Website
http://www.ibsagroup.com

Evaluation of the Efficacy and Safety of Diclofenac HPBCD 25, 50 mg/ml in the Treatment of Post-surgical Pain Following Dental Surgery

Phase 3
Completed
Conditions
Dental Pain
Interventions
Drug: Diclofenac HPBCD
Other: Placebo s.c.
First Posted Date
2009-07-21
Last Posted Date
2013-01-28
Lead Sponsor
IBSA Institut Biochimique SA
Target Recruit Count
306
Registration Number
NCT00942448
Locations
🇵🇱

Gabinet Stomatologiczny Bartek, Kobyłka, Poland

🇬🇧

The School of Dentistry; University of Birmingham, Birmingham, United Kingdom

🇵🇱

Niepubliczny Zakład Opieki Zdrowotnej, Warszawa, Poland

and more 3 locations

Subcutaneous Progesterone Versus Vaginal Progesterone Tablets for Luteal Phase Support in In Vitro Fertilization (IVF)

Phase 3
Completed
Conditions
In Vitro Fertilization
Interventions
First Posted Date
2009-01-23
Last Posted Date
2013-01-31
Lead Sponsor
IBSA Institut Biochimique SA
Target Recruit Count
800
Registration Number
NCT00828191
Locations
🇺🇸

Idaho Center for Reproductive Medicine, Boise, Idaho, United States

🇺🇸

Center for Assisted Reproduction, Bedford, Texas, United States

🇺🇸

Seattle Reproductive Medicine, Seattle, Washington, United States

and more 5 locations

Subcutaneous Progesterone Versus Vaginal Progesterone Gel for Luteal Phase Support in Patients Undergoing In-Vitro Fertilization (IVF)

Phase 3
Completed
Conditions
In Vitro Fertilization
Interventions
First Posted Date
2009-01-23
Last Posted Date
2013-01-31
Lead Sponsor
IBSA Institut Biochimique SA
Target Recruit Count
683
Registration Number
NCT00827983
Locations
🇨🇭

IIRM SA, Sorengo, Ticino, Switzerland

🇨🇭

Universitätsfrauenklinik Basel, Basel, Switzerland

🇭🇺

First Dept. Obstetric and Gynaecology, Semmelweiss University Faculty of Medicine, Budapest, Hungary

and more 11 locations

Efficacy Study of Intra-articular Hyaluronic Acid in the Knee Osteoarthritis

Phase 4
Completed
Conditions
Osteoarthritis, Knee
Interventions
Device: Sinovial® (syringe containing sodium hyaluronate solution)
Device: Synvisc® ( syringe containing Hylan G-F 20 solution)
First Posted Date
2007-11-12
Last Posted Date
2012-12-04
Lead Sponsor
IBSA Institut Biochimique SA
Target Recruit Count
381
Registration Number
NCT00556608
Locations
🇨🇿

Centrum léčby pohybového aparátu spol. s.r.o., Praha, Czech Republic

🇫🇷

University Hospital Centre Bois-Guillaume, Bois Guillaume, France

🇮🇹

Medicina e Traumatologia dello Sport - AzUSL 2 Lucca, Lucca, Italy

and more 17 locations

Prospective, Randomized, Controlled, Clinical Study on Tolerability and Efficacy of hMG-IBSA

Phase 3
Completed
Conditions
Infertility
First Posted Date
2007-04-23
Last Posted Date
2007-04-23
Lead Sponsor
IBSA Institut Biochimique SA
Target Recruit Count
160
Registration Number
NCT00464607
Locations
🇮🇹

Ospedale S. Martino, Genova, Italy

🇮🇹

Ospedale Federico II, Napoli, Italy

🇮🇹

Ospedale S. Anna, Torino, Italy

and more 1 locations

Endometrial Effects of Daily Progesterone s.c. 25 and 50 Mg Aqueous Formulation to Female Healthy Volunteers

Phase 1
Completed
Conditions
Healthy
First Posted Date
2006-09-19
Last Posted Date
2006-09-20
Lead Sponsor
IBSA Institut Biochimique SA
Target Recruit Count
24
Registration Number
NCT00377923

Clinical Efficacy and Tolerability of Two FSH Preparations (Human FSH Versus rFSH - Follitropin Alpha) in Women Undergoing IVF

Phase 3
Completed
Conditions
Infertility
First Posted Date
2006-09-19
Last Posted Date
2015-02-16
Lead Sponsor
IBSA Institut Biochimique SA
Target Recruit Count
152
Registration Number
NCT00378001
Locations
🇺🇸

San Diego Fertility Center, San Diego, California, United States

🇺🇸

Fertility Physicians of Northern California, Palo Alto, California, United States

🇺🇸

UCSF In Vitro Fertilization, San Francisco, California, United States

and more 1 locations

Clinical Tolerance and Equivalence of hCG-IBSA vs Recombinant Human Chorionic Gonadotrophin in Women Undergoing In Vitro Fertilisation

Phase 3
Completed
Conditions
Infertility
First Posted Date
2006-06-12
Last Posted Date
2011-06-01
Lead Sponsor
IBSA Institut Biochimique SA
Target Recruit Count
144
Registration Number
NCT00335569
Locations
🇨🇭

4. Department of Gynecology and Obstetrics Frauenklinik, InselspitalEffingerstrasse 102, Bern, Switzerland

🇨🇭

3. Maternity CHUV - Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

🇨🇭

Department of Gynecology and Obstetrics Universitätfrauenklinik, Basel, Switzerland

and more 1 locations

Efficacy and Tolerability of Human FSH Versus Recombinant FSH (Follitropin Alpha) in ICSI.

Phase 3
Completed
Conditions
Infertility
Interventions
First Posted Date
2006-06-12
Last Posted Date
2015-03-27
Lead Sponsor
IBSA Institut Biochimique SA
Target Recruit Count
151
Registration Number
NCT00335725
Locations
🇭🇺

Semmelweis Medical School, Budapest, Hungary

🇫🇷

Hôpital Edouard Herriot, Lyon, France

🇫🇷

Institut de Médecine de la Reproduction, Marseille, France

and more 4 locations

Clinical Study of Clinical Efficacy and Tolerability of hMG-IBSA s.c.in Women Undergoing COH in an ART Programme (IVF).

Phase 3
Completed
Conditions
Infertility
First Posted Date
2006-06-12
Last Posted Date
2010-03-10
Lead Sponsor
IBSA Institut Biochimique SA
Target Recruit Count
144
Registration Number
NCT00335894
Locations
🇮🇹

Università degli Studi di Bologna, Bologna, Italy

🇮🇹

Università degli Studi di Napoli Federico II, Napoli, Italy

© Copyright 2025. All Rights Reserved by MedPath